市场调查报告书
商品编码
1290902
神经科学市场:现状分析与预测(2022-2030年)Neuroscience Market: Current Analysis and Forecast (2022-2030) |
由于神经系统疾病的患病率不断增加以及神经科学研究的进步,神经科学市场预计将以 4% 左右的速度稳定增长。此外,神经系统疾病发病率和患病率的上升、人们对神经退行性疾??病的认识不断增强以及脑外伤数量的增加也推动了该市场的增长。例如,据世界卫生组织称,2021年将有超过5500万人被诊断出患有痴呆症,每年新增病例近1000万。2019年,全球有5000万人被诊断患有癫痫症。
为了更好地了解神经科学行业的市场采用情况,市场包括北美(美国、加拿大、北美其他地区)、欧洲(德国、英国、法国、西班牙、意大利、欧洲其他地区)、亚太地区(中国) 、日本、印度)。、亚太地区其他地区)以及世界其他国家/地区。预计北美在预测期内将以显着的复合年增长率增长。这主要是由于神经系统疾病的患病率不断上升、医疗保健成本不断上升以及该地区越来越多地采用先进的神经科学技术。
Neuroscience is a multidisciplinary field that incorporates phonetics, calculation, theory, brain science, and science. Neuroscience investigates the cellular, operational, behavioral, molecular, evolutionary, and therapeutic aspects of the neurotic system. Neuroscience research involves a variety of techniques, including brain imaging, electrophysiology, and genetic engineering, and is driving new discoveries in areas such as neurodegeneration, neuropsychiatric disorders, and neural engineering. Moreover, growing mergers and acquisitions between players or investments in research activities will also drive the growth of this market. For instance, in December 2020, Eli Lilly and Company announced that it will buy Win Therapeutics for USD 800 million in a drug bargain. As a result of the acquisition agreement, Eli Lilly & Company will develop a new method for drug discovery and development. This new gene therapy initiative will expand the company's research activities.
The neuroscience market is expected to grow at a steady rate of around 4% owing to the growing prevalence of neurological disorders and advancements in neuroscience research. Furthermore, the growth of this market is also driven owing to the rising incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases, and growth in the number of traumatic brain injuries. For instance, as per WHO, more than 55 million people were diagnosed with dementia in 2021, and there are nearly 10 million new cases every year. Also, in 2019, globally, 50 million people were diagnosed with epilepsy.
Based on component, the market is segmented into instruments, software, and services. The Instruments category is to witness a higher CAGR during the forecast period. These instruments provide accurate and detailed information about the brain, enabling clinicians to diagnose and treat neurological disorders more effectively. Moreover, advances in instrument technology have led to the development of brain-computer interfaces (BCIs), which allow patients with paralysis and other neurological conditions to communicate and control devices with their thoughts. The increasing demand for advanced instruments in neuroscience research and clinical applications is driving the growth of the neuroscience market.
On the basis of end-user, the market is categorized into hospitals, diagnostic laboratories, research, and academic institutes, and others. Among these, the hospitals held a significant share of the market in 2021. This is mainly due to the high preference of patients for hospitalization to have a more accurate diagnosis of their neurological diseases, increasing prevalence of neurological disorders, coupled with the rising demand for personalized medicine, is driving the growth of the healthcare provider segment in the neuroscience market.
For a better understanding of the market adoption of the neuroscience industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing prevalence of neurological disorders, rising healthcare expenditure, and the growing adoption of advanced neuroscience technologies in the region. Additionally, +
Some of the major players operating in the market include: Carl ZEISS AG; Leica Microsystems; General Electric; Siemens; Koninklijke Philips N.V.; TOSHIBA CORPORATION; Hitachi, Ltd.; ESAOTE SPA; HAAG-STREIT GROUP; and Optofine Instruments Pvt. Ltd.